109 related articles for article (PubMed ID: 30982571)
1. The effect of preoperative nutritional status on postoperative complications and overall survival in patients undergoing pelvic exenteration: A multi-disciplinary, multi-institutional cohort study.
Lyell NJ; Kitano M; Smith B; Gleisner AL; Backes FJ; Cheng G; McCarter MD; Abdel-Misih S; Jones EL
Am J Surg; 2019 Aug; 218(2):275-280. PubMed ID: 30982571
[TBL] [Abstract][Full Text] [Related]
2. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
4. Nutrition-related predictors of complications and length of hospital stay following total pelvic exenteration surgery.
Watt A; Kaushik V; Harris C; Yeung CH; Lam YN; Osland E
Clin Nutr ESPEN; 2024 Aug; 62():88-94. PubMed ID: 38901953
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
Katory M; McLean R; Paez E; Kucukmetin A; Naik R
Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
[TBL] [Abstract][Full Text] [Related]
6. A single-institution approach to total pelvic exenteration.
Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
[TBL] [Abstract][Full Text] [Related]
7. Preoperative nutritional status impacts clinical outcome and hospital length of stay in pelvic exenteration patients - a retrospective study.
Hogan S; Steffens D; Vuong K; Rangan A; Solomon M; Carey S
Nutr Health; 2022 Mar; 28(1):41-48. PubMed ID: 33858255
[TBL] [Abstract][Full Text] [Related]
8. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
9. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Gallotta V; Margariti AP; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):880-4. PubMed ID: 24685828
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
12. Urgent Pelvic Exenteration: Should the Indication Be Extended?
Thiptanakit C; Chowchankit I; Panya S; Kanjanasilp P; Malakorn S; Pattana-Arun J; Sahakitrungruang C
Dis Colon Rectum; 2018 May; 61(5):561-566. PubMed ID: 29624550
[TBL] [Abstract][Full Text] [Related]
13. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
[TBL] [Abstract][Full Text] [Related]
15. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Albumin Is Predictive of Early Postoperative Morbidity and Mortality in Common Urologic Oncologic Surgeries.
Caras RJ; Lustik MB; Kern SQ; McMann LP; Sterbis JR
Clin Genitourin Cancer; 2017 Apr; 15(2):e255-e262. PubMed ID: 27765612
[TBL] [Abstract][Full Text] [Related]
17. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
[TBL] [Abstract][Full Text] [Related]
18. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
[TBL] [Abstract][Full Text] [Related]
20. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
